|1.||Bruehl, Stephen: 11 articles (05/2014 - 09/2002)|
|2.||Hopp, Michael: 10 articles (12/2015 - 11/2008)|
|3.||Dahan, Albert: 10 articles (01/2012 - 02/2003)|
|4.||Ling, Walter: 9 articles (12/2015 - 09/2003)|
|5.||Tamaddonfard, Esmaeal: 9 articles (09/2015 - 08/2007)|
|6.||Fiellin, David A: 9 articles (02/2015 - 03/2011)|
|7.||Zarrindast, Mohammad-Reza: 9 articles (04/2014 - 05/2002)|
|8.||Reimer, Karen: 8 articles (12/2015 - 11/2008)|
|9.||Burns, John W: 8 articles (05/2014 - 09/2002)|
|10.||Capasso, Anna: 8 articles (11/2010 - 02/2002)|
03/01/1987 - "Twenty-two patients who experienced excellent pain relief from chronic PAG-PVG stimulation received intravenous naloxone in a double-blind, placebo-controlled protocol. "
08/01/1986 - "Patients receiving naloxone had significantly greater intraoperative i beta-END and pain as compared with those receiving placebo. "
01/01/1983 - "EP amplitude enhancement with naloxone was significantly greater following 20 min of shocks than preceding them, while pain judgments were not significantly affected. "
01/01/2004 - "The reduction of the naloxone infusion rate effectively relieved the increased pain, and no supplemental analgesic was used in any patients during the naloxone infusion. "
01/01/2000 - "His pain was relieved with naloxone. "
|2.||Respiratory Insufficiency (Respiratory Failure)
01/01/2014 - "Protective effects have been observed with training individuals at high risk of overdose and prescribing them naloxone, an opioid antagonist that reverses the effects of the opioid-induced respiratory depression that causes death. "
12/01/1980 - "Respiratory depression was treated successfully with naloxone."
05/12/2014 - "Intranasal naloxone is as effective as IV naloxone in reversing both respiratory depression and depressive effects on the central nervous system caused by opioid overdose."
01/03/2005 - "IN naloxone is effective in treating opiate-induced respiratory depression, but is not as effective as IM naloxone. "
09/05/2014 - "While, a single injection of naloxone (150.0 μg/kg, i.m.) only achieved partial remission of respiratory depression. "
06/01/2002 - "Pretreatment with naloxone before HS attenuated the protective effects in a dose-dependent fashion, with significant attenuation of protection occurring at 15 mg/kg naloxone versus heat shock (42 +/- 6 vs. 16 +/- 3%, P < 0.001). "
11/01/1988 - "Naloxone treatment improved blood pressure significantly during endotoxin shock, as would be expected with the observed increase in total peripheral vascular resistance and no significant change in cardiac output. "
08/01/1980 - "In endotoxin shock in rats, naloxone's effects were stereospecific and were observed with intravenous (iv) doses as low as 0.1 mg/kg. In endotoxin shock in dogs, naloxone treatment significantly improved both cardiovascular parameters and survival. "
01/01/2003 - "Many case reports have suggested that naloxone (an opiate antagonist) might be an effective treatment for shock in humans, but others have not supported such a point of view. "
10/01/1989 - "Naloxone and shed blood were equally effective in improving hepatic and renal blood flow; gastric, intestinal, pancreatic, and splenic blood flow remained unchanged from shock values in both groups. "
08/01/2011 - "Some of those studies indicated a significant reduction in the frequency or severity of pruritus with use of naloxone (a low-dose, continuous i.v. infusion of naloxone appeared to be the most effective treatment). "
07/01/1985 - "Intravenous naloxone significantly decreased the incidence of pruritus during labor and delivery. "
10/01/1997 - "Naloxone had been shown to be effective in relieving pruritus of dialyzed patients. "
09/01/2009 - "Naloxone is safe and efficacious in symptomatic improvement in cholestatic pruritus."
07/01/2011 - "Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: a meta-analysis."
08/01/2015 - "An international double-blind randomized placebo controlled study evaluated the safety and efficacy of four doses of a new sustained release naloxone capsule to treat Opioid Induced Constipation (OIC). "
10/01/2014 - "Enteral naloxone may be effective in treating opioid-induced constipation; however, further studies are warranted."
10/01/2014 - "To determine the safety and efficacy of enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit (MICU). "
03/01/1997 - "In conclusion, it was found that the treatment of opioid-induced constipation by administration of oral naloxone produced positive results. "
07/01/1992 - "Oral naloxone ameliorates opioid-induced constipation in opioid-dependent persons. "
|1.||Morphine (MS Contin)
|3.||Opioid Receptors (Opioid Receptor)
|7.||Opioid Analgesics (Opioids)
|8.||Narcotic Antagonists (Opioid Antagonists)